Literature DB >> 24462112

Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization.

B Ashok Reddy1, Jan A van der Knaap1, Alice G M Bot1, Adone Mohd-Sarip1, Dick H W Dekkers2, Mieke A Timmermans3, John W M Martens3, Jeroen A A Demmers2, C Peter Verrijzer4.   

Abstract

Nucleotide biosynthesis is fundamental to normal cell proliferation as well as to oncogenesis. Tumor suppressor p53, which prevents aberrant cell proliferation, is destabilized through ubiquitylation by MDM2. Ubiquitin-specific protease 7 (USP7) plays a dualistic role in p53 regulation and has been proposed to deubiquitylate either p53 or MDM2. Here, we show that guanosine 5'-monophosphate synthase (GMPS) is required for USP7-mediated stabilization of p53. Normally, most GMPS is sequestered in the cytoplasm, separated from nuclear USP7 and p53. In response to genotoxic stress or nucleotide deprivation, GMPS becomes nuclear and facilitates p53 stabilization by promoting its transfer from MDM2 to a GMPS-USP7 deubiquitylation complex. Intriguingly, cytoplasmic sequestration of GMPS requires ubiquitylation by TRIM21, a ubiquitin ligase associated with autoimmune disease. These results implicate a classic nucleotide biosynthetic enzyme and a ubiquitin ligase, better known for its role in autoimmune disease, in p53 control.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24462112     DOI: 10.1016/j.molcel.2013.12.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  45 in total

1.  Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity.

Authors:  A Bianchi-Smiraglia; J A Wawrzyniak; A Bagati; E K Marvin; J Ackroyd; S Moparthy; W Bshara; E E Fink; C E Foley; G E Morozevich; A E Berman; D S Shewach; M A Nikiforov
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

Review 2.  Precision autophagy directed by receptor regulators - emerging examples within the TRIM family.

Authors:  Tomonori Kimura; Michael Mandell; Vojo Deretic
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

3.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

4.  Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).

Authors:  Mi Lai; Lizhu Liang; Jiwei Chen; Naiqi Qiu; Sai Ge; Shuhui Ji; Tieliu Shi; Bei Zhen; Mingwei Liu; Chen Ding; Yi Wang; Jun Qin
Journal:  Mol Cell Proteomics       Date:  2016-04-25       Impact factor: 5.911

Review 5.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

Review 6.  TRIMming p53's anticancer activity.

Authors:  S Elabd; G Meroni; C Blattner
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

7.  E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2.

Authors:  Madhanagopal Anandapadamanaban; Nikolaos C Kyriakidis; Veronika Csizmók; Amélie Wallenhammar; Alexander C Espinosa; Alexandra Ahlner; Adam R Round; Jill Trewhella; Martin Moche; Marie Wahren-Herlenius; Maria Sunnerhagen
Journal:  J Biol Chem       Date:  2019-06-03       Impact factor: 5.157

8.  Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

Authors:  Benshang Li; Hui Li; Yun Bai; Renate Kirschner-Schwabe; Jun J Yang; Yao Chen; Gang Lu; Gannie Tzoneva; Xiaotu Ma; Tongmin Wu; Wenjing Li; Haisong Lu; Lixia Ding; Huanhuan Liang; Xiaohang Huang; Minjun Yang; Lei Jin; Hui Kang; Shuting Chen; Alicia Du; Shuhong Shen; Jianping Ding; Hongzhuan Chen; Jing Chen; Arend von Stackelberg; Longjun Gu; Jinghui Zhang; Adolfo Ferrando; Jingyan Tang; Shengyue Wang; Bin-Bing S Zhou
Journal:  Nat Med       Date:  2015-05-11       Impact factor: 53.440

9.  Plasma Autoantibodies Associated with Basal-like Breast Cancers.

Authors:  Jie Wang; Jonine D Figueroa; Garrick Wallstrom; Kristi Barker; Jin G Park; Gokhan Demirkan; Jolanta Lissowska; Karen S Anderson; Ji Qiu; Joshua LaBaer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-12       Impact factor: 4.254

Review 10.  Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis.

Authors:  Demond Williams; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2019-05-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.